Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel Group, Dose-Response Study of SDP-4 Ophthalmic Solution in Subjects With Dry Eye Disease (DED)
Conditions
Interventions
SDP-4 Ophthalmic Solution (0.1%)
SDP-4 Ophthalmic Solution (1.0%)
+2 more
Locations
26
United States
Canyon City Eyecare
Azusa, California, United States
Orange County Ophthalmology Medical Group
Garden Grove, California, United States
North Valley Eye Medical Group
Mission Hills, California, United States
LoBue Laser and Eye Medical Center
Murrieta, California, United States
Eye Research Foundation
Newport Beach, California, United States
North Bay Eye Associates
Petaluma, California, United States
Start Date
April 16, 2019
Primary Completion Date
October 7, 2019
Completion Date
October 11, 2019
Last Updated
September 2, 2022
NCT07463950
NCT07363824
NCT07396441
NCT07298811
NCT07295691
NCT07191847
Lead Sponsor
Silk Technologies, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions